LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in HamstersVIRUSES-BASELIF3.52023-06-214OAAI
Development of a dual vaccine against East Coast fever and lumpy skin diseaseFRONTIERS IN IMMUNOLOGYIF5.92023-03-304OAAI
A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamstersFRONTIERS IN PLANT SCIENCEIF4.82023-03-0714OAAI
Augmenting glycosylation-directed folding pathways enhances the fidelity of HIV Env immunogen production in plantsBIOTECHNOLOGY AND BIOENGINEERINGIF3.62022-07-198OA
Investigating Constraints Along the Plant Secretory Pathway to Improve Production of a SARS-CoV-2 Spike Vaccine CandidateFRONTIERS IN PLANT SCIENCEIF4.82022-01-049OAAI
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIVVACCINESIF3.42021-11-054OAAI
Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamianaFRONTIERS IN PLANT SCIENCEIF4.82021-07-2212OAAI
N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in PlantsFRONTIERS IN PLANT SCIENCEIF4.82021-06-1539OAAI
A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed FoldingFRONTIERS IN PLANT SCIENCEIF4.82020-12-0320OAAI
Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in AfricaNATURE REVIEWS MICROBIOLOGYIF103.32020-09-1040OAAI
Engineering the Plant Secretory Pathway for the Production of Next-Generation PharmaceuticalsTRENDS IN BIOTECHNOLOGYIF14.92020-09-0138PREAI
Co-expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plantsPLANT BIOTECHNOLOGY JOURNALIF10.52020-03-1350OAAI
Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like ParticlesVACCINESIF3.42020-01-2915OAAI
Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 ImmunogensFRONTIERS IN PLANT SCIENCEIF4.82019-10-3026OAAI
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting VirusJOURNAL OF VIROLOGYIF3.82019-04-1535OAAI
Production of complex viral glycoproteins in plants as vaccine immunogensPLANT BIOTECHNOLOGY JOURNALIF10.52018-07-0661OAAI